Medtronic, Inc.

Greatbatch Ltd.

Nuvectra Corporation

Intelect Medical, Inc.

Nextern Innovation, LLC

Other

Boston Scientific Neuromodulation Corporation

Medtronics, Inc.

Greatbach Ltd.

Cultiv8 Medical, LLC

Cirtec Medical Corporation

Thd S.p.a.

Qig Group, LLC

John Matthew Swoyer

Jesse D Geroy

Martin T Gerber

James Finley

Shahn S Sage

Michele Spinelli

Mark A Christopherson

Lawrence Kane

Keith Richard Carlton

George Mamo

Steven David Hartle

Scott Kokones

Warren L Starkebaum

Ahmed M Elmouelhi

Scott F Drees

Carole A Tronnes

Yelena G Tropsha

Elliot Bridgeman

Julie M Woessner

Richard Boydston North

Valerie J Glazier

Scott Brainard

Jeff Gagnon

Allison M Kidder

Rafael Carbunaru

Todd K Whitehurst

John Michael Barker

Kristen N Jaax

Andrew DiGiore

Brett Daniel Schleicher

Matthew Braden Flowers

Courtney C Lane

Jonathan T Lawson

James Carl Makous

Steven Siegel

Qingshan Ye

Ellis Garai

Bryan J Zart

Robert A Munoz

Martin T Steele, Sr

Tom Walch

Jeffrey Zweber

Alexander O Lakanu

David J DeSmet

Terry Ferrell

Fernando Buarque

Greg A Theis

Richard M Farrell

Giancarlo Barolat

Tim Herbert

Timothy G Laske

Joseph F Lessar

Terry D Daglow

Patrick T Cahalan

Arthur J Coury

Kenneth R Brennen

Timothy W Holleman

Kenneth W Keeney

James E Upton

Peter B McIntyre

Thomas R Skwarek

Phong D Doan

Ryan J Douglas

Jeffrey S Gagnon

Jon F Urban

Scott J Davis

Edward D Di Domenico

Annette Hebzynski

Diane M Radloff

Peter B Mc Intyre

Annette M Hebzynski

Christopher Narveson

John D Foley

Jim Makous

Riazul Islam

Brian K Farrell

Keith Carlson

George J Mano

Jeffrey Sweber

Thomas Delmar Schmelzer

Jeff S Gagnon

Scott Drees

Elliot W Bridgeman

Matt Flowers

Andrew Digiore

Apparatus and associated methods relate to cell culture systems having controlled gas concentration boundary conditions around cell culture. In an illustrative example, a programmable cell culture system (PCCS) may include one or more manifolds, each releasably coupled to multiple cell culture modules. The cell culture modules, for example, may include a nutrient capacitive medium (NCM) in fluid communication with a concentration-controlled gas source through at least two gas transfer interfaces. The gas transfer interfaces (GTIs) may, for example, be spatially distributed in relation to a cell growth surface in the NCM. Each GTI, for example, may include a gas permeable membrane (GPM) and a plenum. The GPM may be disposed between the plenum and the NCM. Various embodiments may advantageously selectively control a concentration of at least one target gas in the NCM by maintaining predetermined boundary conditions of the cell growth surface via the GTIs.

Cell culture system with controlled gas transfer boundary conditions

Disclosed are various examples and embodiments of systems, devices, components and methods configured to treat a patient using a compact implantable neurostimulator and corresponding lead(s) that are shaped, sized and configured to be implanted beneath a patient's skin in the head or neck, and to stimulate one or more target cranial nerves. The one or more medical electrical leads comprising electrode(s) are positioned adjacent to, in contact with, or in operative positional relationship to, the one or more target cranial nerves of the patient. In some embodiments, electrical stimulation is provided to the one or more target cranial nerve(s) of the patient for periods of time ranging between 30 and 60 minutes, once or twice per day. In some embodiments, power is provided to the implantable neurostimulator transcutaneously by inductive, wireless, RF, acoustic, microwave, or other suitable non-invasive means.

Systems, devices, components and methods for the delivery of electrical stimulation to cranial nerves

Apparatus and associated methods relate to a valve having an actuator configured to translate a mass in a plane and a valve element located out of the first plane and configured to translate along a first linear axis. In an illustrative example, at least one of the mass and the valve element may include a magnetic source providing a persistent magnetic field and the other may include a non-magnetized, magnetically permeable mass. Reluctance-induced forces may, for example, translate the valve element towards the mass along the first linear axis when the mass is brought into register with a second linear axis. The first linear axis and the second linear axis may, for example, be colinear. Various embodiments may advantageously provide a valve requiring low energy input for operation.

Valve actuation system through permanent magnet use

Apparatus and associated methods relate to a lead that includes metallic traces sandwiched between layers of polymers to form a ribbon (e.g., similar to a flex circuit). In an illustrative example, areas on both ends of the traces may be exposed, forming stimulation electrodes on one end and electrical contacts on the other. The ribbon may be formed such that it fits down a small diameter needle. When the needle is removed, the formed ribbon may relax and engage the tissue providing a means of retention. The lead may advantageously: (1) be minimally invasive to implant, (2) be inexpensive, (3) stay in place a temporary/trial medical procedure setting, and (4) be easy to remove.

Lead for the temporary stimulation of a peripheral nerve

Disclosed are various examples and embodiments of systems, devices, components and methods configured to treat mood disorders in a patient using a compact implantable neurostimulator and corresponding lead(s) that are shaped, sized and configured to be implanted beneath a patient's skin in the head or neck, and to stimulate one or more target cranial nerves. The one or more medical electrical leads comprising electrode(s) are positioned adjacent to, in contact with, or in operative positional relationship to, the one or more target cranial nerves of the patient. In some embodiments, electrical stimulation is provided to the one or more target cranial nerve(s) of the patient for periods of time ranging between 30 and 60 minutes, once or twice per day. In some embodiments, power is provided to the implantable neurostimulator transcutaneously by inductive, wireless, RF, acoustic, microwave, or other suitable non-invasive means.

Systems, devices, components and methods for the delivery of electrical stimulation to cranial nerves to treat mood or mood affective disorders

A therapy assembly configured for at least partial insertion in a living body. At least one fixation structure is attached to the therapy delivery element proximate the electrodes. The fixation structure is configured to collapse radially inward and wrap circumferentially around the therapy delivery element to a collapsed configuration when inserted into a lumen of an introducer. The fixation structures deploy to a deployed configuration when the introducer is retracted. The fixation structure includes major surfaces generally parallel with, and extending radially outward from, a central axis of the therapy delivery element, proximal edge surface oriented toward the proximal end, and a distal edge surface oriented toward the distal end. The proximal and distal edge surfaces provide generally symmetrical resistance to displacement of the therapy delivery element within the living body in either a proximal direction or a distal direction along the central axis.

Lead positioning and finned fixation system

A method of making a therapy delivery element configured for at least partial insertion in a living body is disclosed. A conductor structure is coiled around a mandrel. A segment of the conductor structure is secured to the mandrel. After this, an outer tubular structure is positioned around the conductor structure. Portions of the conductor structure that are not secured are free to expand to an inside surface of the outer tubular structure. A lumen is formed by removing at least a portion of the mandrel.

Manufacturing method of a dynamic coil for implantable stimulation leads

A therapy delivery element configured for at least partial insertion in a living body. A braided structure surrounds the conductor assembly. A distal end of the braided structure is attached to an electrode assembly and a free floating proximal end is located near a connector assembly. An outer tubing surrounds the braided structure. The outer tubing includes a proximal end attached to the connector assembly and a distal end attached to the braided structure near the electrode assembly. A proximal tension force applied to the connector assembly acts substantially on the outer tubing and the conductor assembly and a proximal tension force applied to the free floating proximal end acts substantially on the braided structure.

Lead with braided reinforcement

In some examples, a lead identification system includes a first set of first lead indicators and a second set of second lead indicators. Each of the first lead indicators is configured to removably attach to at least one of a first therapy delivery element, a first epidural needle, or a first connector to uniquely identify at least one of the first therapy delivery element, the first epidural needle, or the first connector during implantation of the first therapy delivery element in the patient. Each of the second lead indicators is configured to removably attach to at least one of a second therapy delivery element, a second epidural needle, or a second connector to uniquely identify at least one of the second therapy delivery element, the second epidural needle, or the second connector during implantation of the second therapy delivery element in the patient.

Lead identification system

In various examples, an apparatus includes a stimulation lead including an elongate body including a distal end and a proximal end. At least one first electrode is disposed proximate the distal end of the elongate body and is configured to stimulate a first target nerve. At least one second electrode is disposed between the at least one first electrode and the proximal end of the elongate body and is configured to stimulate a second target nerve. At least one first fixation structure is disposed between the at least one second electrode and the proximal end of the elongate body. The at least one first fixation structure is configured to anchor the stimulation lead proximate the sacrum, wherein the at least one first fixation structure is located on the elongate body and spaced a first distance proximally along the elongate body from the at least one first electrode.

Implantable medical lead for stimulation of multiple nerves

An implantable stimulation lead has electrode contacts that are configured to deliver an electrical stimulation therapy for a patient. A sheath extends along a longitudinal axis. The sheath defines a lumen into which the stimulation lead can be inserted. A distal end of the sheath includes a plurality of base segments that are separated from one another. A plurality of fixation structures are located on the base segments, respectively. In a first configuration, the fixation structures are each disposed proximate to the sheath. In a second configuration, the fixation structures each extend radially outward from the sheath. In a third configuration, the base segments deflect radially inward toward the longitudinal axis.

Implantable medical lead with collapsible fixation member

In some examples, a method of making a therapy delivery element configured for at least partial insertion in a living body includes braiding a plurality of fibers to form an elongated braided structure with a lumen. At least one reinforcing structure is weaved into the fibers of the braided structure. A portion of the reinforcing structure is extended from the braided structure to form at least one fixation structure. At least one of the braided structure or the reinforcing structure can be attached to at least one of an electrode assembly or a connector assembly.

Braided lead with embedded fixation structures

Growing community of inventors

Andover, MN, United States of America

John Matthew Swoyer